Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05292781 · ClinicalTrials.gov registry record · NA

CHOICES3: Sickle Cell Disease Parenting CHOICES

A NA study of Sickle Cell Disease and Sickle Cell Trait, sponsored by University of Florida.

Active
Registry status
NA
Development phase
506
Enrollment target
1
Study location

NCT05292781 is a NA study of Sickle Cell Disease and Sickle Cell Trait that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 506 participants, above the 290-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (74% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05292781, a NA study of Sickle Cell Disease and Sickle Cell Trait, is active but no longer recruiting, sponsored by University of Florida.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
506 participants
Enrollment target
1
Study location

Study Summary

The study will use web-based data collection (SCKnowIQ) and intervention delivery strategies enhanced by nudges and tailored boosters in a sample of 430 adult men and women, aged 18-45 yr with SCD (Sickle Cell Disease) or SCT (Sickle Cell Trait), at-risk, and planning within 2 years to have a child free of SCD.

Interventions

  • OTHER CHOICES
  • OTHER eBook

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 506 participants
Start Date 2022-12-01
Est. Completion 2027-06-30
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT05292781

The ClinicalTrials.gov registry entry for NCT05292781 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 506 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 290-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (74% higher). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Sickle Cell Disease appearing as the primary indexed condition, and to 2 interventions - of which CHOICES is the first listed.

NCT05292781 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05292781 about?

NCT05292781 is a clinical study titled "CHOICES3: Sickle Cell Disease Parenting CHOICES". The study will use web-based data collection (SCKnowIQ) and intervention delivery strategies enhanced by nudges and tailored boosters in a sample of 430 adult men and women, aged 18-45 yr with SCD (Sickle Cell Disease) or SCT (Sickle Cell Trait), at-risk, and planning within 2 years to have a child ...

What is the current status of trial NCT05292781?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 506 participants. The study started on 2022-12-01. Estimated completion is 2027-06-30.

What conditions does trial NCT05292781 study?

This clinical trial studies the following conditions: Sickle Cell Disease, Sickle Cell Trait.

What interventions are being tested in trial NCT05292781?

The interventions under investigation include: CHOICES (OTHER), eBook (OTHER).

Who is sponsoring clinical trial NCT05292781?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05292781 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.